カテゴリー： QYResearch, 世界

世界のT細胞抗原Gp39市場 2019年

【英語タイトル】Global T Cell Antigen Gp39 Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X16231）・商品コード：DATA909X16231
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：105
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、T細胞抗原Gp39の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ECI-006、B型肝炎ワクチン、INX-021、ISF-35、その他に、用途別には、移植片対宿主病、乳がん、膀胱がん、膵臓がん、その他にセグメント区分し、T細胞抗原Gp39の世界市場を分析しました。


・エグゼクティブ・サマリー
・T細胞抗原Gp39の世界市場概要
・T細胞抗原Gp39の製造コスト構成分析
・T細胞抗原Gp39の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・T細胞抗原Gp39の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・T細胞抗原Gp39のセグメント分析（種類別）
（ECI-006、B型肝炎ワクチン、INX-021、ISF-35、その他）
・T細胞抗原Gp39のセグメント分析（用途別）
（移植片対宿主病、乳がん、膀胱がん、膵臓がん、その他）
・T細胞抗原Gp39の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Biogen, Inc.、Bristol-Myers Squibb Company、eTheRNA Immunotherapies NV、ImmuNext, Inc.、Juno Therapeutics Inc.、MedImmune, LLC、Targovax AS、XL-protein GmbH、）
・T細胞抗原Gp39の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global T Cell Antigen Gp39 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on T Cell Antigen Gp39 volume and value at global level, regional level and company level. From a global perspective, this report represents overall T Cell Antigen Gp39 market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of T Cell Antigen Gp39 in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their T Cell Antigen Gp39 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Biogen, Inc.
Bristol-Myers Squibb Company
eTheRNA Immunotherapies NV
ImmuNext, Inc.
Juno Therapeutics Inc.
MedImmune, LLC
Targovax AS
XL-protein GmbH

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
ECI-006
Hepatitis B vaccine
INX-021
ISF-35
Others

Segment by Application
Graft Versus Host Disease
Breast Cancer
Bladder Cancer
Panceratic Cancer
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of T Cell Antigen Gp39
1.1 Definition of T Cell Antigen Gp39
1.2 T Cell Antigen Gp39 Segment by Type
1.2.1 Global T Cell Antigen Gp39 Production Growth Rate Comparison by Types (2014-2025)
1.2.2 ECI-006
1.2.3 Hepatitis B vaccine
1.2.4 INX-021
1.2.5 ISF-35
1.2.6 Others
1.3 T Cell Antigen Gp39 Segment by Applications
1.3.1 Global T Cell Antigen Gp39 Consumption Comparison by Applications (2014-2025)
1.3.2 Graft Versus Host Disease
1.3.3 Breast Cancer
1.3.4 Bladder Cancer
1.3.5 Panceratic Cancer
1.3.6 Others
1.4 Global T Cell Antigen Gp39 Overall Market
1.4.1 Global T Cell Antigen Gp39 Revenue (2014-2025)
1.4.2 Global T Cell Antigen Gp39 Production (2014-2025)
1.4.3 North America T Cell Antigen Gp39 Status and Prospect (2014-2025)
1.4.4 Europe T Cell Antigen Gp39 Status and Prospect (2014-2025)
1.4.5 China T Cell Antigen Gp39 Status and Prospect (2014-2025)
1.4.6 Japan T Cell Antigen Gp39 Status and Prospect (2014-2025)
1.4.7 Southeast Asia T Cell Antigen Gp39 Status and Prospect (2014-2025)
1.4.8 India T Cell Antigen Gp39 Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of T Cell Antigen Gp39
2.3 Manufacturing Process Analysis of T Cell Antigen Gp39
2.4 Industry Chain Structure of T Cell Antigen Gp39

3 Development and Manufacturing Plants Analysis of T Cell Antigen Gp39
3.1 Capacity and Commercial Production Date
3.2 Global T Cell Antigen Gp39 Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of T Cell Antigen Gp39
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 T Cell Antigen Gp39 Production and Capacity Analysis
4.2 T Cell Antigen Gp39 Revenue Analysis
4.3 T Cell Antigen Gp39 Price Analysis
4.4 Market Concentration Degree

5 T Cell Antigen Gp39 Regional Market Analysis
5.1 T Cell Antigen Gp39 Production by Regions
5.1.1 Global T Cell Antigen Gp39 Production by Regions
5.1.2 Global T Cell Antigen Gp39 Revenue by Regions
5.2 T Cell Antigen Gp39 Consumption by Regions
5.3 North America T Cell Antigen Gp39 Market Analysis
5.3.1 North America T Cell Antigen Gp39 Production
5.3.2 North America T Cell Antigen Gp39 Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America T Cell Antigen Gp39 Import and Export
5.4 Europe T Cell Antigen Gp39 Market Analysis
5.4.1 Europe T Cell Antigen Gp39 Production
5.4.2 Europe T Cell Antigen Gp39 Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe T Cell Antigen Gp39 Import and Export
5.5 China T Cell Antigen Gp39 Market Analysis
5.5.1 China T Cell Antigen Gp39 Production
5.5.2 China T Cell Antigen Gp39 Revenue
5.5.3 Key Manufacturers in China
5.5.4 China T Cell Antigen Gp39 Import and Export
5.6 Japan T Cell Antigen Gp39 Market Analysis
5.6.1 Japan T Cell Antigen Gp39 Production
5.6.2 Japan T Cell Antigen Gp39 Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan T Cell Antigen Gp39 Import and Export
5.7 Southeast Asia T Cell Antigen Gp39 Market Analysis
5.7.1 Southeast Asia T Cell Antigen Gp39 Production
5.7.2 Southeast Asia T Cell Antigen Gp39 Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia T Cell Antigen Gp39 Import and Export
5.8 India T Cell Antigen Gp39 Market Analysis
5.8.1 India T Cell Antigen Gp39 Production
5.8.2 India T Cell Antigen Gp39 Revenue
5.8.3 Key Manufacturers in India
5.8.4 India T Cell Antigen Gp39 Import and Export

6 T Cell Antigen Gp39 Segment Market Analysis (by Type)
6.1 Global T Cell Antigen Gp39 Production by Type
6.2 Global T Cell Antigen Gp39 Revenue by Type
6.3 T Cell Antigen Gp39 Price by Type

7 T Cell Antigen Gp39 Segment Market Analysis (by Application)
7.1 Global T Cell Antigen Gp39 Consumption by Application
7.2 Global T Cell Antigen Gp39 Consumption Market Share by Application (2014-2019)

8 T Cell Antigen Gp39 Major Manufacturers Analysis
8.1 Biogen, Inc.
8.1.1 Biogen, Inc. T Cell Antigen Gp39 Production Sites and Area Served
8.1.2 Biogen, Inc. Product Introduction, Application and Specification
8.1.3 Biogen, Inc. T Cell Antigen Gp39 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bristol-Myers Squibb Company
8.2.1 Bristol-Myers Squibb Company T Cell Antigen Gp39 Production Sites and Area Served
8.2.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
8.2.3 Bristol-Myers Squibb Company T Cell Antigen Gp39 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 eTheRNA Immunotherapies NV
8.3.1 eTheRNA Immunotherapies NV T Cell Antigen Gp39 Production Sites and Area Served
8.3.2 eTheRNA Immunotherapies NV Product Introduction, Application and Specification
8.3.3 eTheRNA Immunotherapies NV T Cell Antigen Gp39 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 ImmuNext, Inc.
8.4.1 ImmuNext, Inc. T Cell Antigen Gp39 Production Sites and Area Served
8.4.2 ImmuNext, Inc. Product Introduction, Application and Specification
8.4.3 ImmuNext, Inc. T Cell Antigen Gp39 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Juno Therapeutics Inc.
8.5.1 Juno Therapeutics Inc. T Cell Antigen Gp39 Production Sites and Area Served
8.5.2 Juno Therapeutics Inc. Product Introduction, Application and Specification
8.5.3 Juno Therapeutics Inc. T Cell Antigen Gp39 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 MedImmune, LLC
8.6.1 MedImmune, LLC T Cell Antigen Gp39 Production Sites and Area Served
8.6.2 MedImmune, LLC Product Introduction, Application and Specification
8.6.3 MedImmune, LLC T Cell Antigen Gp39 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Targovax AS
8.7.1 Targovax AS T Cell Antigen Gp39 Production Sites and Area Served
8.7.2 Targovax AS Product Introduction, Application and Specification
8.7.3 Targovax AS T Cell Antigen Gp39 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 XL-protein GmbH
8.8.1 XL-protein GmbH T Cell Antigen Gp39 Production Sites and Area Served
8.8.2 XL-protein GmbH Product Introduction, Application and Specification
8.8.3 XL-protein GmbH T Cell Antigen Gp39 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of T Cell Antigen Gp39 Market
9.1 Global T Cell Antigen Gp39 Market Trend Analysis
9.1.1 Global T Cell Antigen Gp39 Market Size (Volume and Value) Forecast 2019-2025
9.2 T Cell Antigen Gp39 Regional Market Trend
9.2.1 North America T Cell Antigen Gp39 Forecast 2019-2025
9.2.2 Europe T Cell Antigen Gp39 Forecast 2019-2025
9.2.3 China T Cell Antigen Gp39 Forecast 2019-2025
9.2.4 Japan T Cell Antigen Gp39 Forecast 2019-2025
9.2.5 Southeast Asia T Cell Antigen Gp39 Forecast 2019-2025
9.2.6 India T Cell Antigen Gp39 Forecast 2019-2025
9.3 T Cell Antigen Gp39 Market Trend (Product Type)
9.4 T Cell Antigen Gp39 Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 T Cell Antigen Gp39 Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of T Cell Antigen Gp39
Table Global T Cell Antigen Gp39 Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global T Cell Antigen Gp39 Production Market Share by Types in 2018
Figure ECI-006 Product Picture
Figure Hepatitis B vaccine Product Picture
Figure INX-021 Product Picture
Figure ISF-35 Product Picture
Figure Others Product Picture
Table Global T Cell Antigen Gp39 Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global T Cell Antigen Gp39 Consumption Market Share by Applications in 2018
Figure Graft Versus Host Disease
Figure Breast Cancer
Figure Bladder Cancer
Figure Panceratic Cancer
Figure Others
Figure Global T Cell Antigen Gp39 Revenue (Million USD) (2014-2025)
Figure Global T Cell Antigen Gp39 Production (K Pcs) (2014-2025)
Figure North America T Cell Antigen Gp39 Market Size (Million USD) (2014-2025)
Figure Europe T Cell Antigen Gp39 Market Size (Million USD) (2014-2025)
Figure China T Cell Antigen Gp39 Market Size (Million USD) (2014-2025)
Figure Japan T Cell Antigen Gp39 Market Size (Million USD) (2014-2025)
Figure Southeast Asia T Cell Antigen Gp39 Market Size (Million USD) (2014-2025)
Figure India T Cell Antigen Gp39 Market Size (Million USD) (2014-2025)
Table T Cell Antigen Gp39 Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of T Cell Antigen Gp39 in 2018
Figure Manufacturing Process Analysis of T Cell Antigen Gp39
Figure Industry Chain Structure of T Cell Antigen Gp39
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global T Cell Antigen Gp39 Manufacturing Plants Distribution
Table T Cell Antigen Gp39 Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table T Cell Antigen Gp39 Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table T Cell Antigen Gp39 Production (K Pcs) of Major Manufacturers (2014-2019)
Table T Cell Antigen Gp39 Production Market Share of Major Manufacturers (2014-2019)
Figure T Cell Antigen Gp39 Production Share by Manufacturers in 2018
Table T Cell Antigen Gp39 Revenue (Million US$) of Major Manufacturers (2014-2019)
Table T Cell Antigen Gp39 Revenue Market Share of Major Manufacturers (2014-2019)
Figure T Cell Antigen Gp39 Revenue Share by Manufacturers in 2018
Table T Cell Antigen Gp39 Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global T Cell Antigen Gp39 Production by Regions 2014-2019 (K Pcs)
Table Global T Cell Antigen Gp39 Production Market Share by Regions 2014-2019
Figure Global T Cell Antigen Gp39 Production Market Share by Regions in 2018
Table Global T Cell Antigen Gp39 Revenue by Regions 2014-2019 (Million USD)
Table Global T Cell Antigen Gp39 Revenue Market Share by Regions 2014-2019
Figure Global T Cell Antigen Gp39 Revenue Market Share by Regions in 2018
Table Global T Cell Antigen Gp39 Consumption by Regions 2014-2019 (K Pcs)
Table Global T Cell Antigen Gp39 Consumption Market Share by Regions 2014-2019
Figure North America T Cell Antigen Gp39 Production Growth Rate 2014-2019 (K Pcs)
Figure North America T Cell Antigen Gp39 Revenue Growth Rate 2014-2019 (Million USD)
Table North America T Cell Antigen Gp39 Production, Consumption Import and Export (K Pcs)
Figure Europe T Cell Antigen Gp39 Production Growth Rate 2014-2019 (K Pcs)
Figure Europe T Cell Antigen Gp39 Revenue Growth Rate 2014-2019 (Million USD)
Table Europe T Cell Antigen Gp39 Production, Consumption Import and Export (K Pcs)
Figure China T Cell Antigen Gp39 Production Growth Rate 2014-2019 (K Pcs)
Figure China T Cell Antigen Gp39 Revenue Growth Rate 2014-2019 (Million USD)
Table China T Cell Antigen Gp39 Production, Consumption Import and Export (K Pcs)
Figure Japan T Cell Antigen Gp39 Production Growth Rate 2014-2019 (K Pcs)
Figure Japan T Cell Antigen Gp39 Revenue Growth Rate 2014-2019 (Million USD)
Table Japan T Cell Antigen Gp39 Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia T Cell Antigen Gp39 Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia T Cell Antigen Gp39 Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia T Cell Antigen Gp39 Production, Consumption Import and Export (K Pcs)
Figure India T Cell Antigen Gp39 Production Growth Rate 2014-2019 (K Pcs)
Figure India T Cell Antigen Gp39 Revenue Growth Rate 2014-2019 (Million USD)
Table India T Cell Antigen Gp39 Production, Consumption Import and Export (K Pcs)
Figure Global Consumption T Cell Antigen Gp39 Market Share by Application (2014-2019)
Figure Global Value (Consumption) T Cell Antigen Gp39 Market Share by Application (2014-2019)
Table Biogen, Inc. T Cell Antigen Gp39 Production Sites and Area Served
Table Biogen, Inc. T Cell Antigen Gp39 Product Introduction, Application and Specification
Table Biogen, Inc. T Cell Antigen Gp39 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biogen, Inc. T Cell Antigen Gp39 Production Growth Rate (2014-2019)
Table Biogen, Inc. T Cell Antigen Gp39 Production Market Share (2014-2019)
Figure Biogen, Inc. T Cell Antigen Gp39 Revenue Market Share (2014-2019)
Table Biogen, Inc. T Cell Antigen Gp39 Main Business and Markets Served
Table Bristol-Myers Squibb Company T Cell Antigen Gp39 Production Sites and Area Served
Table Bristol-Myers Squibb Company T Cell Antigen Gp39 Product Introduction, Application and Specification
Table Bristol-Myers Squibb Company T Cell Antigen Gp39 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Company T Cell Antigen Gp39 Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Company T Cell Antigen Gp39 Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Company T Cell Antigen Gp39 Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Company T Cell Antigen Gp39 Main Business and Markets Served
Table eTheRNA Immunotherapies NV T Cell Antigen Gp39 Production Sites and Area Served
Table eTheRNA Immunotherapies NV T Cell Antigen Gp39 Product Introduction, Application and Specification
Table eTheRNA Immunotherapies NV T Cell Antigen Gp39 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table eTheRNA Immunotherapies NV T Cell Antigen Gp39 Production Growth Rate (2014-2019)
Table eTheRNA Immunotherapies NV T Cell Antigen Gp39 Production Market Share (2014-2019)
Figure eTheRNA Immunotherapies NV T Cell Antigen Gp39 Revenue Market Share (2014-2019)
Table eTheRNA Immunotherapies NV T Cell Antigen Gp39 Main Business and Markets Served
Table ImmuNext, Inc. T Cell Antigen Gp39 Production Sites and Area Served
Table ImmuNext, Inc. T Cell Antigen Gp39 Product Introduction, Application and Specification
Table ImmuNext, Inc. T Cell Antigen Gp39 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ImmuNext, Inc. T Cell Antigen Gp39 Production Growth Rate (2014-2019)
Table ImmuNext, Inc. T Cell Antigen Gp39 Production Market Share (2014-2019)
Figure ImmuNext, Inc. T Cell Antigen Gp39 Revenue Market Share (2014-2019)
Table ImmuNext, Inc. T Cell Antigen Gp39 Main Business and Markets Served
Table Juno Therapeutics Inc. T Cell Antigen Gp39 Production Sites and Area Served
Table Juno Therapeutics Inc. T Cell Antigen Gp39 Product Introduction, Application and Specification
Table Juno Therapeutics Inc. T Cell Antigen Gp39 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Juno Therapeutics Inc. T Cell Antigen Gp39 Production Growth Rate (2014-2019)
Table Juno Therapeutics Inc. T Cell Antigen Gp39 Production Market Share (2014-2019)
Figure Juno Therapeutics Inc. T Cell Antigen Gp39 Revenue Market Share (2014-2019)
Table Juno Therapeutics Inc. T Cell Antigen Gp39 Main Business and Markets Served
Table MedImmune, LLC T Cell Antigen Gp39 Production Sites and Area Served
Table MedImmune, LLC T Cell Antigen Gp39 Product Introduction, Application and Specification
Table MedImmune, LLC T Cell Antigen Gp39 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table MedImmune, LLC T Cell Antigen Gp39 Production Growth Rate (2014-2019)
Table MedImmune, LLC T Cell Antigen Gp39 Production Market Share (2014-2019)
Figure MedImmune, LLC T Cell Antigen Gp39 Revenue Market Share (2014-2019)
Table MedImmune, LLC T Cell Antigen Gp39 Main Business and Markets Served
Table Targovax AS T Cell Antigen Gp39 Production Sites and Area Served
Table Targovax AS T Cell Antigen Gp39 Product Introduction, Application and Specification
Table Targovax AS T Cell Antigen Gp39 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Targovax AS T Cell Antigen Gp39 Production Growth Rate (2014-2019)
Table Targovax AS T Cell Antigen Gp39 Production Market Share (2014-2019)
Figure Targovax AS T Cell Antigen Gp39 Revenue Market Share (2014-2019)
Table Targovax AS T Cell Antigen Gp39 Main Business and Markets Served
Table XL-protein GmbH T Cell Antigen Gp39 Production Sites and Area Served
Table XL-protein GmbH T Cell Antigen Gp39 Product Introduction, Application and Specification
Table XL-protein GmbH T Cell Antigen Gp39 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table XL-protein GmbH T Cell Antigen Gp39 Production Growth Rate (2014-2019)
Table XL-protein GmbH T Cell Antigen Gp39 Production Market Share (2014-2019)
Figure XL-protein GmbH T Cell Antigen Gp39 Revenue Market Share (2014-2019)
Table XL-protein GmbH T Cell Antigen Gp39 Main Business and Markets Served
Figure Global T Cell Antigen Gp39 Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global T Cell Antigen Gp39 Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global T Cell Antigen Gp39 Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America T Cell Antigen Gp39 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America T Cell Antigen Gp39 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe T Cell Antigen Gp39 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe T Cell Antigen Gp39 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China T Cell Antigen Gp39 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China T Cell Antigen Gp39 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan T Cell Antigen Gp39 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan T Cell Antigen Gp39 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia T Cell Antigen Gp39 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia T Cell Antigen Gp39 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India T Cell Antigen Gp39 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India T Cell Antigen Gp39 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of T Cell Antigen Gp39 by Type (2019-2025)
Table Global Consumption (K Pcs) of T Cell Antigen Gp39 by Application (2019-2025)
Table T Cell Antigen Gp39 Distributors List
Table T Cell Antigen Gp39 Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Biogen, Inc.、Bristol-Myers Squibb Company、eTheRNA Immunotherapies NV、ImmuNext, Inc.、Juno Therapeutics Inc.、MedImmune, LLC、Targovax AS、XL-protein GmbH、

★調査レポート[世界のT細胞抗原Gp39市場 2019年] (コード：DATA909X16231)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のT細胞抗原Gp39市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のB細胞成熟抗原（BCMA）標的療法市場 2019年
    DATA909X04452 / QYResearch / 2019年11月15日 / ※本調査レポートは、B細胞成熟抗原（BCMA）標的療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、二重特異性抗体、抗体薬物コンジュゲート、キメラ抗原受容体T細胞に、用途別には、肝臓がん、呼吸器がん、脳がん、その他にセグメント区分し、B細胞成熟抗原（BCMA）標的療法の世界市場を分析しました。 ・エグゼクティブ・サマリー ・B細胞成熟抗原（BCMA）標的療法の世界市場概要 ・B細胞成熟抗原（BCMA）標的療法の製造コスト構成分析 ・B細胞成熟抗原（BCMA）標的療法の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・B細胞成熟抗原（BCMA）標的療法の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・B細胞成熟抗原（BCMA）標的療法のセグメント分析（種類別） （二重特異性抗体、抗体薬物コンジュゲート、キメラ抗原受容体T細胞）...The global B-Cell Maturation Antigen(BCMA) Targeted Therapies market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on B-Cell Maturation Antigen(BCMA) Targeted Therapies volume and value at global level, regional level and company level. From a global perspective, this report represents overall B-Cell Maturation Antigen(BCMA) Targeted Therapies market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of B-Cell Maturation Antigen(BCMA) Targeted Therapies in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のCD抗原がん療法市場 2019年
    DATA909X05230 / QYResearch / 2019年11月15日 / ※本調査レポートは、CD抗原がん療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、モノクローナル抗体、抗体薬物複合体、三機能性および二重特異性T細胞エンゲージ抗体、その他、に、用途別には、病院、診療所、その他にセグメント区分し、CD抗原がん療法の世界市場を分析しました。 ・エグゼクティブ・サマリー ・CD抗原がん療法の世界市場概要 ・CD抗原がん療法の製造コスト構成分析 ・CD抗原がん療法の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・CD抗原がん療法の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・CD抗原がん療法のセグメント分析（種類別） （モノクローナル抗体、抗体薬物複合体、三機能性および二重特異性T細胞エンゲージ抗体、その他、）...The global CD Antigen Cancer Therapy market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on CD Antigen Cancer Therapy volume and value at global level, regional level and company level. From a global perspective, this report represents overall CD Antigen Cancer Therapy market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of CD Antigen Cancer Therapy in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の白血球表面抗原CD47市場 2019年
    DATA909X10504 / QYResearch / 2019年11月20日 / ※本調査レポートは、白血球表面抗原CD47の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、B-6H12、ALX-148、CC-90002、PSTx-23、その他に、用途別には、リンパ腫、卵巣癌、虚血再灌流障害、腎移植拒絶、その他にセグメント区分し、白血球表面抗原CD47の世界市場を分析しました。 ・エグゼクティブ・サマリー ・白血球表面抗原CD47の世界市場概要 ・白血球表面抗原CD47の製造コスト構成分析 ・白血球表面抗原CD47の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・白血球表面抗原CD47の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・白血球表面抗原CD47のセグメント分析（種類別） （B-6H12、ALX-148、CC-90002、PSTx-23、その他）...The global Leukocyte Surface Antigen CD47 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Leukocyte Surface Antigen CD47 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Leukocyte Surface Antigen CD47 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Leukocyte Surface Antigen CD47 in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の前立腺特異抗原市場 2019年
    DATA909X13816 / QYResearch / 2019年11月20日 / ※本調査レポートは、前立腺特異抗原の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、G-115、INO-5150、ADXS-PSA、AEZS-120、その他に、用途別には、前立腺がん、転移ホルモン抵抗性前立腺がん、その他にセグメント区分し、前立腺特異抗原の世界市場を分析しました。 ・エグゼクティブ・サマリー ・前立腺特異抗原の世界市場概要 ・前立腺特異抗原の製造コスト構成分析 ・前立腺特異抗原の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・前立腺特異抗原の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・前立腺特異抗原のセグメント分析（種類別） （G-115、INO-5150、ADXS-PSA、AEZS-120、その他）...The global Prostate Specific Antigen market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Prostate Specific Antigen volume and value at global level, regional level and company level. From a global perspective, this report represents overall Prostate Specific Antigen market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Prostate Specific Antigen in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の細胞性腫瘍抗原p53市場 2019年
    DATA909X05261 / QYResearch / 2019年11月15日 / ※本調査レポートは、細胞性腫瘍抗原p53の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、COTI-2、D-12PGJ3、APR-246、ATRN-502、セネルセンナトリウム、MJ-05、MX-225、その他に、用途別には、卵巣がん、前立腺がん、脳がん、その他にセグメント区分し、細胞性腫瘍抗原p53の世界市場を分析しました。 ・エグゼクティブ・サマリー ・細胞性腫瘍抗原p53の世界市場概要 ・細胞性腫瘍抗原p53の製造コスト構成分析 ・細胞性腫瘍抗原p53の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・細胞性腫瘍抗原p53の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・細胞性腫瘍抗原p53のセグメント分析（種類別） （COTI-2、D-12PGJ3、APR-246、ATRN-502、セネルセンナトリウム、MJ-05、MX-225、その他）...The global Cellular Tumor Antigen p53 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cellular Tumor Antigen p53 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cellular Tumor Antigen p53 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Cellular Tumor Antigen p53 in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • マイコプラズマプレート抗原の世界市場：規模・現状・予測2019-2025
    DATA909X18737 / QYResearch / 2019年11月25日 / ※当調査レポートでは、マイコプラズマプレート抗原の世界市場について調査・分析し、マイコプラズマプレート抗原の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（プレート凝集試験製品、確認試験試薬）、用途別（医薬品開発、感染症医学、獣医学研究、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のマイコプラズマプレート抗原市場動向 ・主要企業別マーケットシェア ・マイコプラズマプレート抗原の種類別市場規模2014-2019 （プレート凝集試験製品、確認試験試薬） ・マイコプラズマプレート抗原の用途別市場規模2014-2019 （医薬品開発、感染症医学、獣医学研究、その他） ・マイコプラズマプレート抗原の北米市場：主要企業・種類別/用途別市場規模 ・マイコプラズマプレート抗原のヨーロッパ市場：主要企業・種類別/用途別市場規模...Mycoplasma Plate Antigens are used to detect the antibodies against aetiologic agent of mycoplasma strains that are responsible for developing chronic respiratory disease in chickens and infectious sinusitis in turkeys. Some of the common symptoms of the disease include nasal discharge, coughing, airsacculitis and respiratory rales.In 2018, the global Mycoplasma Plate Antigen market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Mycoplasma Plate Antigen status, future forecast, growth opportunity, key market and key players. The study...
  • 腫瘍特異抗原の世界市場：規模・現状・予測2019-2025
    DATA909X19057 / QYResearch / 2019年11月25日 / ※当調査レポートでは、腫瘍特異抗原の世界市場について調査・分析し、腫瘍特異抗原の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（コーディング領域、非コーディング領域）、用途別（創薬、開発、診断、臨床＆基礎研究、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の腫瘍特異抗原市場動向 ・主要企業別マーケットシェア ・腫瘍特異抗原の種類別市場規模2014-2019 （コーディング領域、非コーディング領域） ・腫瘍特異抗原の用途別市場規模2014-2019 （創薬、開発、診断、臨床＆基礎研究、その他） ・腫瘍特異抗原の北米市場：主要企業・種類別/用途別市場規模 ・腫瘍特異抗原のヨーロッパ市場：主要企業・種類別/用途別市場規模...Tumor-specific Antigen is a new Antigen that is expressed on the surface of certain Tumor cells but not on normal cells.Such antigens may be present in tumors of the same tissue type in different individuals.Tumor-specific antigens help the body develop an immune response to cancer cells.They could be used as potential targets for targeted therapy or immunotherapy to help improve the body's immune system to kill more cancer cells.Tumor-specific antigens can also be used in laboratory tests to help identify certain types of cancer.In 2018, the global Tumor-Specific Antigen market size was xx million US$ and it is expected to...
  • 前立腺特異抗原（PSA）テストの世界市場：規模・現状・予測2019-2025
    DATA909X18873 / QYResearch / 2019年11月25日 / ※当調査レポートでは、前立腺特異抗原（PSA）テストの世界市場について調査・分析し、前立腺特異抗原（PSA）テストの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（CLIA法、ELISA法）、用途別（スクリーニング、治療後モニタリング、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の前立腺特異抗原（PSA）テスト市場動向 ・主要企業別マーケットシェア ・前立腺特異抗原（PSA）テストの種類別市場規模2014-2019 （CLIA法、ELISA法） ・前立腺特異抗原（PSA）テストの用途別市場規模2014-2019 （スクリーニング、治療後モニタリング、その他） ・前立腺特異抗原（PSA）テストの北米市場：主要企業・種類別/用途別市場規模 ・前立腺特異抗原（PSA）テストのヨーロッパ市場：主要企業・種類別/用途別市場規模...Prostate-specific antigen (PSA) is a protein secreted only by epithelial prostate cells, and its elevation in serum is used to detect prostate cancer in men.Elevated PSA levels are associated with prostatitis, inflammation of the prostate or benign forms of prostatic hyperplasia, making it a valuable tumor marker for prostate cancer.The use of serology-based biomarkers for the diagnosis of prostate cancer has stimulated the need for prostate-specific antigen (PSA).In 2018, the global Prostate-specific Antigen (PSA) Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx%...

    • ◆H&Iグローバルリサーチのお客様（例）◆